Efficacy and safety of umbilical cord mesenchymal stem cells for the treatment of patients with COVID-19.
Fengtao WeiDexiao KongTao LiAi LiYi TanJinfeng FangXianghua ZhuangChao LaiWeihua XuHong DongChengen MaKe HongYuqin CuiShengbin TangFenggang YuChengyun ZhengPublished in: Clinics (Sao Paulo, Brazil) (2021)
Intravenous infusion of MSCs in patients with COVID-19 was effective and well tolerated. Further studies involving a large cohort or randomized controlled trials are warranted.